Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print  Bacteria Genome Research Could Save Orchards and Assist Blood Transfusions

Bacteria Genome Research Could Save Orchards and Assist Blood Transfusions

August 21, 2007

Research led by the University Warwick into the genomes of two bacteria could save orchards from a previously almost incurable disease and also assist in treating complications arising from human blood transfusions.

The researchers were interested in how the bacteria naturally produced a family of chemicals called desferrioxamines. Desferrioxamine E is produced by the bacterium Erwinia amylovora. The bacterium uses it to damage apple or pear trees and acquire iron from them. This allows it to establish an infection that leads to the economically-damaging agricultural disease known as "Fire Blight" that can sweep through an orchard if the infected trees are not removed. The bacterium Streptomyces coelicolor produces desferrioxamine B, which is used to treat iron overload in humans - for instance following extensive blood transfusions.




By studying the genomes of the two bacteria, the researchers were able to work out that each uses a similar biochemical pathway to produce desferrioxamines. In both cases they use a "remarkable" trimerisation-macrocyclisation reaction cascade in the key step. The researchers purified the enzyme responsible and showed that it could catalyse the reaction cascade in a test tube.

The current industrial process to create desferrioxamine B relies on the fermentation of the bacterium Streptomyces pilosus. The Warwick-led research has identified how Streptomyces bacteria create it using only four enzyme catalysts and four different building blocks. In contrast, the laboratory synthesis of desferrioxamine B requires 10 steps and uses numerous chemicals. Harnessing the enzymes may result in much cheaper pharmaceuticals based on desferrioxamine B and manipulating them could lead to the creation of new orally-active analogues of this important pharmaceutical.

The new understanding of how desferrioxamine E is created by Erwinia amylovora opens the way for the creation of new chemical inhibitors that may prevent this bacterium from inflicting Fire Blight on orchards

The research was led by Professor Greg Challis from the University of Warwick and involved colleagues from the University of Warwick and the Universidad Nacional Autonoma de Mexico. It was published online in Nature Chemical Biology on Sunday 19th of August.

University of Warwick




More Human Blood Transfusions Current Events and Human Blood Transfusions News Articles
Transfusion of human blood

Transfusion of human blood
by Joseph Roussel (Author)

Purchase of this book includes free trial access to www.million-books.com where you can read more than a million books for free. This is an OCR edition with typos. Excerpt from book: apparatus; then close first the afferent and then the efferent branch tube, after all the water and the blood mixed with the water have been ejected. Now, while the blood is flowing from the one animal to the other, the surgeon, to prevent engorgement of the heart and lungs of the recipient, should take the tube by the middle, compress and relax it regularly each second so as to produce rhythmical jets, suspending the current of the blood from the emittent, and diminishing its violence; in this manner by the pulsation of the tube it may be ascertained that the blood is really being transfused. By this...

Saving Lives with Serum Albumin. Doctors today know the riddle of why an injured man, his wounds perfectly treated, may still not recover. He may be a victim of "shock", a dangerous trend toward failure of blood circulation. Unless this trend is promptly reversed, the effect is fatal. Now doctors have anew tool to fight shock - a tool newer than blood transfusions or plasma. This discovery, concentrated Serum Albumin, when used in shock cases, actually draws fluid from the body tissues into the circulation to make up the loss. This Human Serum Albumin is made from the blood you donate. Squibb Laboratories were among the first to produce Serum Albumin for our Armed Forces. ..... 1944 Squibb Ad, A5132.

Saving Lives with Serum Albumin. Doctors today know the riddle of why an injured man, his wounds perfectly treated, may still not recover. He may be a victim of "shock", a dangerous trend toward failure of blood circulation. Unless this trend is promptly reversed, the effect is fatal. Now doctors have anew tool to fight shock - a tool newer than blood transfusions or plasma. This discovery, concentrated Serum Albumin, when used in shock cases, actually draws fluid from the body tissues into the circulation to make up the loss. This Human Serum Albumin is made from the blood you donate. Squibb Laboratories were among the first to produce Serum Albumin for our Armed Forces. ..... 1944 Squibb Ad, A5132.

This Item is an original Magazine ad, taken from a vintage magazine of the year indicated. The ad is suitable for framing and displaying in your home or office. The scan of this item was taken through plastic film, however it is an accurate representation of the item. The nominal size is 10.5 inches by 14 inches.

  ORIGINAL PATENT APPLICATION NUMBER 18,862 FOR A DEVICE FOR THE TRANSFUSION OF BLOOD AND FOR THE INJECTION OF MEDICAMENTS INTO THE HUMAN BODY (CASSEL).
by Julius & Heinrich Lieberg. Lieberg (Author)



The Gift Relationship: From Human Blood to Social Policy

The Gift Relationship: From Human Blood to Social Policy
by Richard Morris Titmuss (Author), Ann Oakley (Editor), John Ashton (Editor)

Richard M. Titmuss's The Gift Relationship has long been acknowledged as one of the classic texts on social policy. A seemingly straightforward comparative study of blood donating in the United States and Britain, the book elegantly raises profound economic, political, and philosophical questions. Titmuss contrasts the British system of reliance on voluntary donors to the American one in which the blood supply is largely in the hands of for-profit enterprises and shows how a nonmarket system based on altruism is more effective than one that treats human blood as another commodity.

  The Beginnings of Blood Transfusion: An entry from Gale's Science and Its Times
by Lois N. Magner (Author)

This digital document is an article from Science and Its Times, brought to you by GaleĀ®, a part of Cengage Learning, a world leader in e-research and educational publishing for libraries, schools and businesses. The length of the article is 1877 words. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. The histories of science, technology, and mathematics merge with the study of humanities and social science in this interdisciplinary reference work. Essays on people, theories, discoveries, and concepts are combined with overviews, bibliographies of primary documents, and chronological elements to offer students a fascinating way to understand the impact of science on the course...

Alternative Approaches to Human Blood Resources in Clinical Practice

Alternative Approaches to Human Blood Resources in Clinical Practice
by C.Th. Smit Sibinga (Editor), P.C. Das (Editor), J.C. Fratantoni (Editor)

Currently blood is a volatile issue. The safety of blood and the quantification of transfusion risks have been dominant themes that have stimulated the development of alternative approaches in this rapidly developing area. In clinical medicine conventional blood and its components are used in supportive therapies dependent on the choice of apparent uncritical trigger factors. A compounding factor is depth of prospective clinical trials for evidence. Such trials in critical care areas would be of enormous value, not only in recording adverse effects and under-transfusion, but also indicating the value of decision analysis and cost-effectiveness in transfusion practice. Alternative approaches include the use of cytokines, growth factors, humanised monoclonal antibodies,...

  Blood Supply: Transfusion-Associated Risks
by BPI Information Services (Author)



Analyzing Personnel Retention Utilizing Multi-Agent Systems

Analyzing Personnel Retention Utilizing Multi-Agent Systems
by Steven J. French (Author)

This is a NAVAL POSTGRADUATE SCHOOL MONTEREY CA report procured by the Pentagon and made available for public release. It has been reproduced in the best form available to the Pentagon. It is not spiral-bound, but rather assembled with Velobinding in a soft, white linen cover. The Storming Media report number is A919683. The abstract provided by the Pentagon follows: As we enter the 21st Century, the Department of Defense finds itself facing a significant personnel crisis. Despite a thirty percent reduction in manpower needs, the military is continually failing to meet its retention requirements. There are numerous factors that are causing this problem, to include the booming US economy, the highest military deployment rates in our history, and the widespread use of the Internet. The...

  Transmission of the human immunodeficiency virus (HIV) through blood transfusions between 1978 and 1985: Information document for Quebec's physicians
by Gouvernement du Quebec, Ministere de la sante et des services sociaux (Publisher)



  Infectious disease testing for blood transfusions : January 1975 through October 1994 : 1888 citations (SuDoc HE 20.3615/2:94-10)
by Martha Glock (Author)



© 2009 BrightSurf.com